These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28621614)

  • 1. Biomarkers in the accurate subclassification of non-small-cell lung carcinoma for targeted therapy: issues and prospects.
    Osmani L; Li QK
    Biomark Med; 2017 May; 11(5):405-407. PubMed ID: 28621614
    [No Abstract]   [Full Text] [Related]  

  • 2. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.
    Osmani L; Askin F; Gabrielson E; Li QK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):103-109. PubMed ID: 29183778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics a novel biomarker in lung cancer.
    Stinkens K; Vanhove K; Thomeer M
    J Thorac Oncol; 2015 Jun; 10(6):e46. PubMed ID: 26001150
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells.
    Pelosi G; Fabbri A; Tamborini E; Perrone F; Testi AM; Settanni G; Busico A; Centonze G; Braidotti P; Bulfamante G; De Braud F; Garassino M; Pastorino U
    J Thorac Oncol; 2015 Oct; 10(10):1500-2. PubMed ID: 26398824
    [No Abstract]   [Full Text] [Related]  

  • 5. IMP3 expression in non-small cell lung cancer.
    Bellezza G; Cavaliere A; Sidoni A
    Hum Pathol; 2009 Aug; 40(8):1205-6. PubMed ID: 19427669
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.
    Koyi H; Brandén E; Kasim I; Wilander E
    Anticancer Res; 2018 Jun; 38(6):3341-3346. PubMed ID: 29848682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verifying the role of surgical pathologists in the precision medicine of lung cancer.
    Cagle PT; Olsen RJ
    Arch Pathol Lab Med; 2013 Sep; 137(9):1176-8. PubMed ID: 23276149
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer.
    Chuang JC; Liang Y; Wakelee HA
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):31-44. PubMed ID: 27912832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
    Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
    Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rapidly evolving landscape of biomarker testing in non-small cell lung cancer.
    VanderLaan PA; Rangachari D; Costa DB
    Cancer Cytopathol; 2021 Mar; 129(3):179-181. PubMed ID: 32757369
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.
    Marrugal Á; Ojeda L; Paz-Ares L; Molina-Pinelo S; Ferrer I
    Dis Markers; 2016; 2016():2138627. PubMed ID: 27445423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.
    Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J
    Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance therapy comes of age for non-small-cell lung cancer, but at what cost?
    Shepherd FA
    J Clin Oncol; 2011 Nov; 29(31):4068-70. PubMed ID: 21969515
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.
    Wang G; Dong W; Shen H; Mu X; Li Z; Lin X; Liu Y; Du J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):1028-32. PubMed ID: 21376622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of proteomics in non-small-cell lung cancer.
    Cho WC
    Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A typical presentation of primary pulmonary epithelioid sarcoma misdiagnosed as non-small cell lung cancer.
    Emori M; Tamakawa M; Kaya M; Takada K; Murase K; Fujita C; Sato S; Takahashi R; Hatanaka KC; Sugita S; Hirano H; Yamashita T; Hasegawa T
    Pathol Int; 2017 Apr; 67(4):222-224. PubMed ID: 28078765
    [No Abstract]   [Full Text] [Related]  

  • 18. 16th World Conference on Lung Cancer.
    Landman A
    Lancet Oncol; 2015 Oct; 16(13):1290. PubMed ID: 26387750
    [No Abstract]   [Full Text] [Related]  

  • 19. PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
    Heymann JJ; Bulman WA; Swinarski D; Pagan CA; Crapanzano JP; Haghighi M; Fazlollahi L; Stoopler MB; Sonett JR; Sacher AG; Shu CA; Rizvi NA; Saqi A
    Cancer Cytopathol; 2017 Dec; 125(12):896-907. PubMed ID: 29024471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress of biomarkers in early stage lung cancer].
    Ouyang Yuqing YQ; Ni Lianfang LF; Liu Xinmin XM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):979-981. PubMed ID: 30522198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.